4503 ORAL Sunitinib in metastatic renal cell carcinoma (mRCC): preliminary assessment of safety and efficacy in an expanded access trial with subpopulation analysis

✍ Scribed by Gore, M.; Szczylik, C.; Porta, C.; Bracarda, S.; Hawkins, R.; Bjarnason, G.; Oudard, S.; Lee, S.H.; Carteni, G.; Eberhardt, W.

• Book ID: 121983173
• Publisher: Elsevier Science
• Year: 2007
• Tongue: English
• Weight: 59 KB
• Volume: 5
• Category: Article
• ISSN: 1359-6349
• DOI: 10.1016/S1359-6349(07)71134-5